Beijing News (Reporter Zhaohui Zhang) On January 24, Sunnyou Medical released its 2023 annual earnings forecast, reporting operating revenue of 730 million to 750 million yuan, representing a year-on-year increase of 49.43% to 53.52%; net profit attributable to shareholders is expected to be between 220 million and 240 million yuan, reflecting a year-on-year growth of 75.34% to 91.28%.
Sunnyou Medical emphasizes the research and development of new products, continuously enriches its rehabilitation product line, and strengthens the layout of its marketing network and the construction of its marketing system. With the removal of factors affecting economic development and the growth in demand for rehabilitation medical services, the company achieved an increase in sales orders during the reporting period, which in turn drove rapid growth in net profit.
Public information shows that Sunnyou, established in 2002, is a research and development enterprise specializing in rehabilitation medical devices. It focuses on the independent research, production, promotion, and sales of intelligent rehabilitation equipment in areas such as orthopedic rehabilitation, neurological rehabilitation, critical care rehabilitation, pain rehabilitation, postpartum rehabilitation, and the integration of medical care and elderly care. The company assists regions across China in building a smart rehabilitation service system that covers all demographics, disease types, and the entire life process.
Proofread by Liu Baoqing